Axten Hospitals Secures Rs 2.5 Crore in Seed Funding ..

Published on:

Axten Hospitals Secures Rs 2.5 Crore in Seed Funding

A Gurugram-based healthcare startup has secured Rs 2.5 crore in its first seed funding round to expand affordable, transparent surgical care. The round was led by PedalStart alongside several angel investors. The company, founded by Gauttam Chhabra, was fully bootstrapped until this infusion.

Investor confidence in a clear-pricing model

Investors have backed the startup after observing early traction and unit economics. They cited the company’s effort to address a persistent issue in India’s private healthcare: opaque surgical pricing and low patient trust. The funding validates the approach and provides capital for measured expansion.

Focus on affordable, high-volume surgeries

The startup concentrates on high-volume procedures in general surgery, orthopaedics, gynaecology, urology, ENT and oncology. Its key proposition is the “Honest Surgery Price” — fixed-price surgery packages that disclose the full cost to patients upfront.

This fixed-pricing approach eliminates surprise bills and reduces financial stress for patients while keeping clinical quality under close oversight. The pilot centre in East of Kailash, New Delhi, delivered strong early results, reporting about Rs 9 crore in revenue in FY25 and achieving positive EBITDA.

Expansion strategy and technology build-out

Using the new funds, the company plans to launch three more facilities within 12 months. It will follow an asset-light model that prioritises partnerships and operational control over heavy capital outlay. This strategy aims to enable new centres to reach break-even in five to six months.

Concurrently, the startup is developing a technology platform to simplify the patient journey — discovery of specialists, transparent price comparisons, online booking and post-operative follow-up. The platform is intended to improve access, reduce friction and support standardised care pathways.

Medium-term targets

Over the next five years, the company aims to scale to more than 25 facilities in major metro markets and target Rs 250 crore in revenue. The plan focuses on cities where demand for quality, affordable and transparent surgical care is high.

Share This ➥